Femasys Inc (FEMY) stock
FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3037% below fair value
$1.12−0.16 (-12.50%)
Close on Nov 17, 2026Market cap $9.38MP/E –Yield –
Femasys operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Femasys's operating income for the twelve months ending Jun 30, 2026 was -$17.57M. For fiscal 2025 it was -$17.59M. The highest annual figure on record is -$6.93M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$17.59M | – |
| FY2024 | Dec 31, 2024 | -$17.79M | – |
| FY2023 | Dec 31, 2023 | -$14.51M | – |
| FY2022 | Dec 31, 2022 | -$11.60M | – |
| FY2021 | Dec 31, 2021 | -$8.34M | – |
| FY2020 | Dec 31, 2020 | -$6.93M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.07M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.22M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.62M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.65M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.85M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.46M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.72M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.12M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.48M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.46M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.45M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.08M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.94M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.04M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.00M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.06M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.66M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.88M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.36M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.25M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.90M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.83M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.66M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.56M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.48M | – |
See a number that looks wrong?